Abstract
Cogan’s syndrome is a rare inflammatory disease characterized by nonsyphilitic ocular interstitial keratitis associated with hearing loss and vestibular impairment. Although systemic corticosteroids are usually used as the standard therapy, hearing ability in most cases gradually deteriorates. We, herein, describe a patient with childhood Cogan’s syndrome who was treated with low-dose oral methotrexate, which successfully helped to taper the doses of the systemic corticosteroids. The serum levels of the complements were good markers for the disease activity in this patient.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cogan D (1945) Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol 33:144–149
Haynes BF, Kaiser-Kupfer MI, Mason P et al (1980) Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) 59:426–441
Grasland A, Pouchot J, Hachulla E et al (2004) Typical and atypical Cogan’s syndrome: 32 cases and review of the literature. Rheumatology (Oxford) 43:1007–1015
Richardson B (1994) Methotrexate therapy for hearing loss in Cogan’s syndrome. Arthritis Rheum 37:1559–1561
Vaiopoulos G, Sfikakis PP, Skoumas B et al (1994) Lack of response to corticosteroids and pulse cyclophosphamide therapy in Cogan’s syndrome. Clin Rheumatol 13:110–112
Pouchot J, Vinceneux P, Bouccara D et al (1995) Methotrexate as a steroid-sparing agent in Cogan’s syndrome: comment on the concise communication by Richardson. Arthritis Rheum 38:1348–1349
Riente L, Taglione E, Berrettini S (1996) Efficacy of methotrexate in Cogan’s syndrome. J Rheumatol 23:1830–1831
Covelli M, Lapadula G, Pipitone V (1999) Cogan’s syndrome: unsuccessful outcome with early combination therapy. Clin Exp Rheumatol 17:479–483
Singsen BH, Goldbach-Mansky R (1997) Methotrexate in the treatment of juvenile rheumatoid arthritis and other pediatric rheumatoid and nonrheumatic disorders. Rheum Dis Clin North Am 23:811–840
Ndiaye IC, Rassi SJ, Wiener-Vacher SR (2002) Cochleovestibular impairment in pediatric Cogan’s syndrome. Pediatrics 109:E38
Martinez-Osorio H, Fuentes-Paez G, Calonge M (2006) Severe keratopathy in paediatric Cogan’s syndrome. Rheumatology (Oxford) 45:1576–1577
Matteson EL, Fabry DA, Facer GW et al (2001) Open trial of methotrexate as treatment for autoimmune hearing loss. Arthritis Rheum 45:146–150
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Inoue, Y., Tomemori, T., Suzuki, S. et al. Low-dose oral methotrexate for the management of childhood Cogan’s syndrome: a case report. Clin Rheumatol 26, 2201–2203 (2007). https://doi.org/10.1007/s10067-007-0686-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-007-0686-y